| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | OPG|Osteoprotegerin|OCIF|TNFRSF11B|OPGtumor necrosis factor receptor superfamily member 11B|Osteoclastogenesis inhibitory factor|Osteoprotegerin|TR1|tumor necrosis factor receptor superfamily|member 11b |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
human OPG (Osteoprotegerin) is a molecular target commonly studied in immunology, cardiovascular, and cancer research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of OPG is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of OPG can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
OPG (Osteoprotegerin) may also be referenced as OPG, Osteoprotegerin, and OCIF in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how OPG relates to innate and adaptive immune responses, cytokine signaling networks, host–pathogen interactions, and immune cell activation and trafficking in immunology, cardiovascular, and cancer research.
- Interpreting shifts in OPG levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
OPG has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with immunology, cardiovascular, and cancer studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Association of rs2073618 polymorphism and osteoprotegerin levels with hypertension and cardiovascular risks in patients with type 2 diabetes mellitus
IF: 4.6 Journal: Scientific Reports Author: Department of Biochemistry, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, 605 006, India Cited Date: 2023-10-20
Hypertension attenuates the link of osteoprotegerin to reduced baroreflex sensitivity in type 2 diabetes mellitus patients on oral antidiabetic and antihypertensive therapy – a cross sectional study
IF: 3.263 Journal: BMC Endocrine Disorders Cited Date: 2022-09-16
Correlation of bone metabolism serum markers with clinical parameters of the disease progression during 2-year follow-up in patients with chronic obstructive pulmonary disease
IF: 1.6 Journal: ?Tzu Chi Medical Journal Author: Department of Medical Chemistry and Biochemistry, Medical Faculty, Trakia University, Stara Zagora, Bulgaria Cited Date: 2025-11-14
Role of Osteoproteherin in Bone Tissue Metabolism in Patients with Osteoarthritis and Obesity
IF: Journal: Achievements of Clinical and Experimental Medicine Cited Date: 2022-04-15
The Effects of Exercise Intensity Difference on Bone Metabolic Markers and Cytokines of the RANKL/RANK/OPG System in Korean Osteopenia Elderly Women
IF: Journal: Exerc Sci. Cited Date: 2017-02-28
GCF Levels of Osteoclastogenesis-Related Cytokines in Periodontitis in Relation to Smoking During Non-Surgical Periodontal Therapy
IF: Journal: Middle Black Sea Journal of Health Science Cited Date: 2023-03-10
Study of Correlation between Serum Osteoprotegerin, TNF-Alfa, and Biomarkers of Bone Metabolism in Patients with Treatment-Naive Graves’ Disease—A Cross-Sectional Study
IF: Journal: Indian Journal of Endocrinology and Metabolism Cited Date: 2023-03-16
Mechanisms of Bone Tissue Remodeling in Young Persons with Osteoarthritis on the Background of Obesity
IF: Journal: Ukrainian Journal of Medicine, Biology and Sport Cited Date: 2022-11-04
Pathogenetic and diagnostic role of osteoprotegerin in the combined course of osteoarthritis and obesity
IF: Journal: Journal of Education, Health and Sport Cited Date: 2022-06-17
Association of osteoprotegerin and lipid risk factors with severity of stenosis in coronary artery disease patients with diabetes mellitus
IF: Journal: Biomedicine Cited Date: 2020-11-19
Effects of 12-week combined exercise on RANKL/RANK/OPG signaling and bone-resorption cytokines in healthy college females
IF: Journal: Journal of Exercise Nutrition & Biochemistry Cited Date: 2019-03-31